The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Endologix, a medtech that focuses on treatments for vascular diseases, expanded its offerings with the purchase of a mechanical thrombectomy system from Surmodics. The deal for the Pounce thrombectomy ...

Endologix has acquired the FDA-cleared Pounce thrombectomy platform to expand its peripheral vascular intervention portfolio. The fully mechanical thrombectomy system is designed for thrombus and ...

Endovascular thrombectomy is indicated for acute ischemic stroke due to a large vessel occlusion in the anterior circulation within 24 hours of the time last known to be well. The ORIENTAL-MeVO ...

Endovascular thrombectomy for acute ischemic stroke due to medium-vessel occlusion has had varying results across trials. Whether thrombectomy improves functional outcomes in patients with ...

Researchers at King's College London have shown for the first time that AI can autonomously perform thrombectomy navigation in a physical lab setting, a step toward expanding access to life-saving ...

Complex percutaneous coronary intervention (PCI) in patients with severely impaired left ventricular function carries a high risk of death and complications. Whether percutaneous left ventricular ...

Landmark, lifesaving telerobotic mechanical thrombectomy to expand access to care for stroke, a leading cause of death and disability worldwide HOUSTON & PANAMA CITY, Panama--(BUSINESS WIRE)--XCath, a ...

MECHANICAL thrombectomy significantly improved right ventricular function compared with anticoagulation alone in patients with intermediate-high risk pulmonary embolism, according to results from the ...

Giving the clot-busting medication alteplase at the site of a blocked brain artery after blood clot removal may increase the number of patients who fully recover, according to preliminary ...

CHOICE2 randomized 400 patients across 14 Spanish centers to thrombectomy alone versus thrombectomy plus intraarterial alteplase, with 90-day mRS as the primary endpoint. Excellent outcomes (mRS 0–1) ...